Presidential approval ratings provide a glimpse of how Americans really feel on any given day, often times driven by his handling of the issues at hand. Here's how Trump is polling after his first ...

While Trump's net approval ratings came out of the gates higher than in 2017, though still lower than those of any other president in modern history, recent polls show public sentiment more split ...

One of just two presidents to serve nonconsecutive terms, his first weeks have provided a unique opportunity to compare his approval ratings against himself at the same point in his first presidency.

While Trump's net approval ratings came out of the gates higher than in 2017, though still lower than those of any other president in modern history, recent polls show public sentiment more split ...

The company states: “Novartis (NVS) announced that oral Fabhalta, iptacopan, has received U.S. Food and Drug Administration approval for the treatment of adults with C3 glomerulopathy ...

Several national surveys show Trump faring the same or better than in previous surveys, with the president holding a significant approval lead over the Democratic Party in a pair of polls.

Several national surveys show Trump faring the same or better than in previous surveys, with the president holding a significant approval lead over the Democratic Party in a pair of polls.

The chamber, which represents Germany's 16 state governments, approved the measure proposed by likely next chancellor Friedrich Merz with the necessary two-thirds majority. Its endorsement ...

Long Island's second-largest nursing home will remain open after a bankruptcy judge Thursday approved a temporary receiver to run Cold Spring Hills Center for Nursing & Rehabilitation, with the ...

Former President Donald Trump has tied his highest approval rating from his first term, reaching 47% according to an NBC poll. Despite the uptick in approval, other polls, such as Reuters/Ipsos ...

NEW YORK — Akero Ther­a­peu­tics may not have ad­e­quate da­ta for ac­cel­er­at­ed ap­proval of its MASH drug, de­spite show­ing it may re­verse cir­rho­sis in pa­tients with … ...